Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance
- PMID: 19182918
- DOI: 10.1089/aid.2008.0168
Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance
Abstract
Abstract The molecular epidemiology of HIV-1 infection was first studied in Cyprus in the mid-1990s, but the extent of HIV-1 diversity and the prevalence of drug resistance have remained elusive. In an effort to address this issue, the present study examined HIV-1 strains isolated from 37 newly diagnosed untreated HIV-1 patients, representing 72% of the total number of newly diagnosed and drug-naive patients in the period 2003 to 2006. DNA sequences encoding the gag (p17, p24, p2, p7, p1, and p6), pol (protease and reverse transcriptase), and env (gp160) regions were amplified by RT-PCR from plasma HIV-1 RNA from all patients and sequenced using a newly designed methodology. All amplified products were studied according to established genetic methodologies to determine the genetic subtype and the prevalence of drug-resistance-associated mutations to currently available antiretroviral drugs. Analyses of the obtained viral sequences indicated that subtype A was the most common subtype present and accounted for 38% of the infections followed by subtype B (35%), subtype C (13%), CRF02_AG (8%), and subtypes D and CRF01_AE (3% each). One patient (2.7%) had an M41L/M and another patient (2.7%) an M184V amino acid substitution in the reverse transcriptase (RT) associated with high-level resistance to RT inhibitors. There were no patients with resistant mutations to protease inhibitors (PI). Additionally, one patient (2.7%) had an L44M amino acid substitution within the HR1 region of gp41 conferring resistance to the enfuvirtide (T20) fusion inhibitor. Similar to results of the 1994 molecular epidemiological study, these data demonstrate the extensive heterogeneity of HIV-1 infection in Cyprus and the low prevalence of transmitted resistance to current HIV-1 antiretroviral drugs. Taken together, these findings demonstrate that HIV-1 infection in Cyprus is being replenished by a continuous influx of new strains from many countries, establishing an ever-evolving and polyphyletic infection in the island.
Similar articles
-
Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance.AIDS Res Hum Retroviruses. 2011 Nov;27(11):1183-99. doi: 10.1089/aid.2011.0060. Epub 2011 May 11. AIDS Res Hum Retroviruses. 2011. PMID: 21453134
-
Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection.AIDS Res Hum Retroviruses. 2009 Aug;25(8):727-40. doi: 10.1089/aid.2008.0239. AIDS Res Hum Retroviruses. 2009. PMID: 19619035
-
Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.J Clin Virol. 2010 Jul;48(3):173-9. doi: 10.1016/j.jcv.2010.04.008. Epub 2010 May 18. J Clin Virol. 2010. PMID: 20483657
-
HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region.Braz J Infect Dis. 2021 May-Jun;25(3):101596. doi: 10.1016/j.bjid.2021.101596. Epub 2021 Jul 13. Braz J Infect Dis. 2021. PMID: 34270996 Free PMC article. Review.
-
HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later.AIDS Rev. 2015 Jul-Sep;17(3):147-58. AIDS Rev. 2015. PMID: 26450803 Review.
Cited by
-
Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men.AIDS Res Hum Retroviruses. 2014 Mar;30(3):225-32. doi: 10.1089/aid.2013.0166. Epub 2013 Oct 18. AIDS Res Hum Retroviruses. 2014. PMID: 24059291 Free PMC article.
-
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe.PLoS One. 2010 Jun 8;5(6):e10976. doi: 10.1371/journal.pone.0010976. PLoS One. 2010. PMID: 20544014 Free PMC article.
-
Origin and dynamics of HIV-1 subtype C infection in India.PLoS One. 2011;6(10):e25956. doi: 10.1371/journal.pone.0025956. Epub 2011 Oct 10. PLoS One. 2011. PMID: 22016790 Free PMC article.
-
Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.AIDS Res Hum Retroviruses. 2014 Aug;30(8):753-68. doi: 10.1089/AID.2013.0262. Epub 2014 Jul 8. AIDS Res Hum Retroviruses. 2014. PMID: 24925216 Free PMC article.
-
Characterization of a novel HIV-1 circulating recombinant form, CRF91_cpx, comprising CRF02_AG, G, J, and U, mostly among men who have sex with men.Virulence. 2022 Dec;13(1):1331-1348. doi: 10.1080/21505594.2022.2106021. Virulence. 2022. PMID: 35979885 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous